U.S. RESEARCH ROUNDUP- Abcellera Biologics, Linde, Spire

Docebo

13/08/2021 08:06

Aug 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Abcellera Biologics, Linde and Spire on Friday. 
    
    HIGHLIGHTS
     * Abcellera Biologics Inc  ABCL.O : Credit Suisse cuts target price to $49 from $51
     * Linde Plc  LIN.N : Jefferies raises target price to $390 from $352
     * Spire Inc  SR.N : JP Morgan raises target price to $83 from $78
        
Following is a summary of research actions on U.S. companies reported by Reuters on Friday.
Stock entries are in alphabetical order.
    
     * Abcellera Biologics Inc  ABCL.O : Credit Suisse cuts target price to $49 from $51
     * Aeva Technologies Inc  AEVA.N : Piper Sandler cuts target price to $12 from $16
     * Apyx Medical Corp  APYX.O : Colliers raises target price to $15 from $14
     * Athene Holding Ltd  ATH.N : JP Morgan cuts target price to $68 from $71
     * Biocryst Pharmaceuticals Inc  BCRX.O : JP Morgan raises target price to $19 from $17
     * Biolife Solutions Inc  BLFS.O : Cowen and Company raises target price to $64 from $50
     * Black Diamond Therapeutics Inc  BDTX.O : JP Morgan cuts target price to $15 from $24
     * Bridge Investment Group Holdings Inc  BRDG.N : JP Morgan raises PT to $19 from $18
     * Broadridge Financial Solutions Inc  BR.N : Piper Sandler raises PT to $180 from $157
     * Broadridge Financial Solutions Inc  BR.N : Raymond James raises PT to $187 from $185
     * Brookfield Asset Management Inc  BAM.N : JP Morgan raises target price to $71 from $69
     * CACI International Inc  CACI.N : Credit Suisse cuts target price to $305 from $307
     * Celsius Holdings Inc  CELH.O : Credit Suisse raises target price to $82 from $78
     * Civista Bancshares Inc  CIVB.O : Piper Sandler raises target price to $26.50 from $25.50
     * Cytokinetics Inc  CYTK.O : Mizuho raises target price to $45 from $36
     * Diamondrock Hospitality Co  DRH.N : Raymond James cuts PT to $10.50 from $11.50
     * Docebo Inc  DCBO.O : Scotiabank raises target price to $73 from $59
     * Doordash Inc  DASH.N : Piper Sandler raises target price to $160 from $130
     * Doordash Inc  DASH.N : RBC raises target price to $210 from $175
     * Eargo Inc  EAR.O : JP Morgan cuts target price to $44 from $52
     * Figs Inc  FIGS.N : Piper Sandler raises target price to $45 from $44
     * Finance of America Companies Inc  FOA.N : Raymond James cuts PT to $10.50 from $13.50
     * First Advantage Corp  FA.O : JP Morgan raises target price to $26 from $24
     * Fulcrum Therapeutics Inc  FULC.O : SVB Leerink raises target price to $37 from $23
     * GCM Grosvenor Inc  GCMG.O : JP Morgan cuts target price to $14.50 from $15
     * Global Medical REIT Inc  GMRE.N : Compass Point raises target price to $17 from $15
     * Humanigen Inc  HGEN.O : Credit Suisse cuts target price to $24 from $25
     * Idexx Laboratories Inc  IDXX.O : Credit Suisse raises target price to $770 from $735
     * Ikena Oncology Inc  IKNA.O : Credit Suisse cuts target price to $27 from $30
     * Integral Ad Science Holding Corp  IAS.O : Barclays raises target price to $22 from $21
     * Intra-Cellular Therapies Inc  ITCI.O : JP Morgan cuts target price to $41 from $44
     * Lifestance Health Group Inc  LFST.O : JP Morgan cuts target price to $24 from $36
     * Linde Plc  LIN.N : Jefferies raises target price to $390 from $352
     * Lions Gate Entertainment Corp  LGFa.N : Barrington Research cuts target price to $20
     * Mediaalpha Inc  MAX.N : JP Morgan cuts target price to $45 from $50
     * Meredith Corp  MDP.N : CFRA raises target price by $4 to $42
     * Metropolitan Bank Holding Corp  MCB.N : JP Morgan raises target price to $115 from $105
     * Mister Car Wash Inc  MCW.N : Jefferies raises target price to $31 from $30
     * Motus Gi Holdings Inc  MOTS.O : Piper Sandler cuts target price to $1.50 from $2.50
     * National Cinemedia Inc  NCMI.O : Barrington Research cuts target price by $1 to $4.50
     * Olema Pharmaceuticals Inc  OLMA.O : JP Morgan raises target price to $49 from $48
     * PGT Innovations Inc  PGTI.N : Truist Securities cuts target price to $25 from $29
     * Points International Ltd  PCOM.O : Acumen Capital raises target price to $25 from $24
     * Radius Health Inc  RDUS.O : JP Morgan cuts target price to $25 from $26
     * Revolution Medicines Inc  RVMD.O : JP Morgan cuts target price to $35 from $43
     * Rocket Companies Inc  RKT.N : Credit Suisse raises target price to $19 from $18
     * Rocket Companies Inc  RKT.N : Piper Sandler raises target price to $20 from $18
     * Sibanye Stillwater Ltd  SBSW.N : RBC cuts target price to $28 from $30
     * Spire Inc  SR.N : JP Morgan raises target price to $83 from $78
     * Summit Hotel Properties Inc  INN.N : Raymond James cuts PT to $10.50 from $11.50
     * UTZ Brands Inc  UTZ.N : Oppenheimer cuts target price to $23 from $27
     * UTZ Brands Inc  UTZ.N : Piper Sandler cuts target price to $24 from $28
     * Vyne Therapeutics Inc  VYNE.O : Piper Sandler cuts target price to $3 from $8
     * Wix.Com Ltd  WIX.O : Oppenheimer cuts target price to $275 from $300
     * Xp Inc  XP.O : JP Morgan raises target price to $50 from $43
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))